Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.
Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny C, Armangué T, Dalmau JO, Querol L, Saiz A. Blanco Y, et al. Among authors: tejada illa c. Neurol Neuroimmunol Neuroinflamm. 2023 Sep 7;10(6):e200163. doi: 10.1212/NXI.0000000000200163. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37679040 Free PMC article.
Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology.
Caballero-Ávila M, Lleixà C, Pascual-Goñi E, Martín-Aguilar L, Vidal-Fernandez N, Tejada-Illa C, Collet-Vidiella R, Rojas-Garcia R, Cortés-Vicente E, Turon-Sans J, Gallardo E, Olivé M, Vesperinas A, Carbayo Á, Llansó L, Martinez-Martinez L, Shock A, Christodoulou L, Dizier B, Freeth J, Soden J, Dawson S, Querol L. Caballero-Ávila M, et al. Among authors: tejada illa c. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200216. doi: 10.1212/NXI.0000000000200216. Epub 2024 Mar 14. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38484217 Free PMC article.
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD.
Pascual-Goñi E, Collet R, Tejada-Illa C, Martín-Aguilar L, Caballero-Ávila M, Lleixà C, Novelli S, López-Pardo J, Sanfeliu AE, Mariscal A, Álvaro Gargallo Y, Martínez-Hernández E, Cocho D, Querol L. Pascual-Goñi E, et al. Among authors: tejada illa c. J Neurol Neurosurg Psychiatry. 2024 Jun 17;95(7):609-611. doi: 10.1136/jnnp-2023-332443. J Neurol Neurosurg Psychiatry. 2024. PMID: 38341197
A nationwide Guillain-Barré syndrome epidemiological study in Spain during the COVID-19 years.
Blanco-Ruiz M, Martín-Aguilar L, Caballero-Ávila M, Lleixà C, Pascual-Goñi E, Collet-Vidiella R, Tejada-Illa C, Turon-Sans J, Carbayo Á, Llansó L, Cortés E, Amaya Pascasio L, Querol L. Blanco-Ruiz M, et al. Among authors: tejada illa c. Eur J Neurol. 2024 Aug 12:e16439. doi: 10.1111/ene.16439. Online ahead of print. Eur J Neurol. 2024. PMID: 39132887